Here’s how to get free Covid at-home tests as cases rise Starting 25 September, all American households can place an order for four free tests The Independent UK · Sep 25, 2023
Here’s how to get free Covid tests Starting 25 September, all American households can place an order for four free tests The Independent UK · Sep 24, 2023
How to get free Covid tests from the government Starting 25 September, all American households can place an order for four free tests The Independent UK · Sep 22, 2023
4 free COVID-19 tests per household will be available Monday — how to get them The Biden administration is providing funding to produce another round of free at-home tests via the COVIDtests.gov program. Chicago Sun-Times · Sep 21, 2023
Biden administration announces $600M to produce COVID tests and will reopen website to order them The Biden administration has announced that it is providing $600 million in funding to produce new at-home COVID-19 tests and is restarting a website allowing Americans to again order up to four free tests per household The Independent UK · Sep 20, 2023
Abortion rights group seeks legal action over emergencies - Roll Call The Center for Reproductive Rights contends bans in three states blocked women from seeking abortions in emergency medical circumstances. Roll Call · Sep 12, 2023
With naloxone now more available, HHS officials tout its use - Roll Call The event, held at HHS headquarters, came during the same week that naloxone became available for purchase without a prescription. Roll Call · Sep 8, 2023
3 Cannabis Stocks to Consider Buying as HHS Recommends Easing Restrictions on Marijuana Cannabis stocks could deliver outsized gains if marijuana is rescheduled, per a recent HHS recommendation. While the DEA weighs its options, here's a look at three names with significant upside potential, according to analysts. Barchart · Sep 7, 2023
35 Years Ago, a Judge Said Marijuana Did Not Belong in Schedule I. HHS Finally Agrees. The 1988 case highlighted the DEA's stubborn insistence that marijuana has no "accepted medical use." Reason · Sep 6, 2023
Marijuana reclassification won’t fix conflict between state, federal laws on pot Moving marijuana from Schedule I to Schedule III would facilitate medical research and benefit pot suppliers, but the federal prohibition on pot use would remain. Chicago Sun-Times · Sep 6, 2023
Rescheduling Marijuana Would Leave Federal Prohibition Essentially Untouched Although the HHS-recommended change would benefit researchers and the cannabis industry, it would not resolve the conflict between state and federal marijuana laws. Reason · Sep 6, 2023
HHS releases long-awaited nursing home staffing proposal - Roll Call The Biden administration's proposed rule would mandate minimum staffing in nursing homes, but it falls short of what advocates had pushed for. Roll Call · Sep 1, 2023
US regulators might change how they classify marijuana. Here's what that would mean When it emerged this week that U.S. health regulators are suggesting that the federal government loosen restrictions on marijuana, the news lit up the world of weed The Independent UK · Aug 31, 2023
What Rescheduling Marijuana Would and Wouldn't Do Although it would leave federal prohibition essentially untouched, the change would facilitate medical research and dramatically reduce taxes on state-licensed suppliers. Reason · Aug 31, 2023
Reason · Aug 31, 2023 The High Costs of Biden's Price-Controlled Drugs Americans will be sicker and deader in the long run than they otherwise would have been.
The Independent UK · Aug 31, 2023 Marijuana users have higher levels of toxic metals in blood and urine, study finds The team of researchers at Columbia University analysed data from blood and urine samples collected between 2005 and 2018 - this is what they found
Reason · Aug 31, 2023 HHS Asks DEA To Reclassify Cannabis as Equivalent to Testosterone and Codeine Tylenol Plus: Tennessee prosecutor threatens to use drag law that was declared unconstitutional, ACLU asks FTC to investigate Mastercard's adult content policy, and more...
The Independent UK · Aug 31, 2023 Senators hail Health Dept. recommendation to ease restrictions on marijuana The U.S. Department of Health and Human Services has delivered a recommendation to the Drug Enforcement Administration on marijuana policy, and Senate leaders are hailing it as a first step toward easing federal restrictions on the drug
Roll Call · Aug 30, 2023 HHS completes review of rescheduling cannabis - Roll Call HHS completed its review of rescheduling cannabis and sent a recommendation to the DEA, the agencies confirmed.
The Independent UK · Aug 30, 2023 Biden health agency recommends classifying marijuana as lower-risk, opening potential for major policy changes President Biden ordered agency to conduct scientific review law year
The Independent UK · Aug 29, 2023 What Biden’s announcement of Medicare negotiating drug prices means Democrats have long wanted to allow Medicare to negotiate drug prices, which it hopes will lead to lower prescription costs
The Guardian - US · Aug 29, 2023 Biden names 10 drugs for first negotiations to cut Medicare prices Government claims prices could fall for 9m seniors but pharma companies claim cost-reduction program is unconstitutional
Roll Call · Aug 29, 2023 HHS lists first 10 drugs subject to Medicare price negotiation - Roll Call The program is a major priority for Joe Biden, who ran for president in part on the promise to allow Medicare to negotiate drug prices.
USAFacts · Aug 25, 2023 How many foster kids end up in permanent homes? Over 600,000 kids pass through the US foster care system annually; some will be adopted, but most will be reunited with their parents.
The Hindu · Aug 25, 2023 Cluster seed fund established for start-ups in Mysuru Mysuru cluster has established a seed fund of ₹25 crore in partnership with State govt, banks and entrepreneurs to provide capital for eligible startups. This is part of Beyond Bengaluru initiative and the industry has grown exponentially in last two years. Reputed companies like IBM, Travancore Analytica, Nagaro, HHS, Proxelera,…